Notice: This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF (CNCR) Dividend Yield, Date & History Add Compare Share Share Dividend Stock AnalysisDividendHeadlinesHoldingsRatingsShort InterestTrends Dividend SummaryDividend Yield2.16%Annual Dividend$0.29Recent Dividend Payment Dec. 31 Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Email Address Skip Charts & View Dividend HistoryCNCR Dividend PaymentsOpen Range Cancer Therapeutics ETF in Dividend Calculator CNCR Dividend Yield Over Time Open Range Cancer Therapeutics ETF in Dividend Yield Calculator Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Range Cancer Therapeutics ETF vs. The CompetitionTypeRange Cancer Therapeutics ETF CompaniesNASDAQ CompaniesAnnual Dividend$0.29$1.35$1.27Dividend Yield2.16%1,523.19%406.06%Annualized 3-Year Dividend Growth0.00%33.61%14.30% Range Cancer Therapeutics ETF Dividend History by QuarterAnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date12/28/2021Annual$1.85307.75%12/29/202112/30/202112/31/202112/29/2020Annual$0.28800.89%12/30/202012/31/20201/4/202112/28/2017annual$0.35021.47%12/28/201712/29/20171/2/2018(Data available from 1/1/2013 forward) Range Cancer Therapeutics ETF Dividend - Frequently Asked Questions What is Range Cancer Therapeutics ETF's dividend yield? The current dividend yield for Range Cancer Therapeutics ETF is 2.16%. Learn more on CNCR's dividend yield history. How much is Range Cancer Therapeutics ETF's annual dividend? The annual dividend for CNCR shares is $0.29. Learn more on CNCR's annual dividend history. How often does Range Cancer Therapeutics ETF pay dividends? Range Cancer Therapeutics ETF pays annual dividends to shareholders. When was Range Cancer Therapeutics ETF's most recent dividend payment? Range Cancer Therapeutics ETF's most recent annual dividend payment of $1.8530 per share was made to shareholders on Friday, December 31, 2021. When was Range Cancer Therapeutics ETF's most recent ex-dividend date? Range Cancer Therapeutics ETF's most recent ex-dividend date was Wednesday, December 29, 2021. When did Range Cancer Therapeutics ETF last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $1.5650 on Tuesday, December 28, 2021. More Dividend Resources from MarketBeat Related Companies JDOC Dividend Yield MEDX Dividend Yield FTXH Dividend Yield BIS Dividend Yield IBBQ Dividend Yield BIB Dividend Yield PTH Dividend Yield PSCH Dividend Yield BBH Dividend Yield PPH Dividend Yield Dividend Tools: Dividend Stocks Overview Dividend Investing Guide Dividend Newsletter Dividend Screener Dividend Capture Stocks Dividend Calculator Dividend Payout Ratio Calculator Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Dividend Announcements Dividend Increases Dividend Cuts Special Dividends Stock Lists: Dividend Stocks Overview Dividend Investing Guide Dividend Newsletter Dividend Screener Dividend Capture Stocks Dividend Calculator Dividend Payout Ratio Calculator Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Dividend Announcements Dividend Increases Dividend Cuts Special Dividends Latest Articles: 3 Best Dividend Stocks to Buy as Interest Rates FallIntuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy3 High-Yield Dividend Stocks for Income Now and Growth LaterDividend King ABM Industries is on Track for New HighsWhy Altria Stock is Still a Good Dividend PlayGet Paid While You Wait - OneMain's Juicy DividendsAlphabet Changes the Narrative with Its First-Ever Dividend3 High Dividend Stocks to Replace Lower Savings Yields Ahead3 Small Dividend Paying Banks Insiders are Buying More Dividend News This page (NASDAQ:CNCR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNCR Stock Alerts